LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions,Designated organic active ingredient containing

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

K-252 derivatives which enhance neurotrophin-induced activity

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

K99-5041 substance and production thereof

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Kahalalide F and compositions and uses thereof

Reissue Patent

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Kainate receptor-selective epimeric analogs of dysiherbaine

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Kallikrein inhibitors and anti-thrombolytic agents and uses...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Kallikrein-binding "Kunitz domain" proteins and analogues thereo

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Kallikrein-inhibiting "kunitz domain" proteins and analogues the

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Kallikrein-inhibitor therapies

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Kallikrein-inhibitor therapies

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Kappa (OP2) opioid receptor antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Kappa agonist anti-pruritic pharmaceutical formulaitons and meth

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Kappa agonist anti-pruritic pharmaceutical formulations and meth

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Kappa agonist anti-pruritic pharmaceutical formulations and meth

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Kappa agonist anti-pruritic pharmaceutical formulations and meth

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Acyclic nitrogen double bonded to acyclic nitrogen – acyclic...

Kappa agonist anti-pruritic pharmaceutical formulations and meth

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Kappa agonist compounds and pharmaceutical formulations thereof

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Kappa agonist compounds and pharmaceutical formulations thereof

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...

Kappa agonist compounds and pharmaceutical formulations thereof

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Kappa agonist compounds and pharmaceutical formulations thereof